Idexx Laboratories (IDXX) Revenue (2009 - 2026)

Idexx Laboratories' Revenue history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Revenue rose 14.26% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.4 billion (up 13.08% YoY), while the FY2025 annual figure was $4.3 billion, up 10.42% from the prior year.
• Revenue for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
• The five-year high for Revenue was $1.1 billion in Q1 2026, with the low at $828.6 million in Q4 2022.
• The 5-year median for Revenue is $954.3 million (2024), against an average of $963.0 million.
• The sharpest annual moves came in 2022 and 2025: Revenue advanced 3.43% in 2022, then increased 14.28% in 2025.
• Idexx Laboratories' Revenue stood at $828.6 million in 2022, then advanced by 8.81% to $901.6 million in 2023, then rose by 5.84% to $954.3 million in 2024, then advanced by 14.28% to $1.1 billion in 2025, then gained by 4.61% to $1.1 billion in 2026.
• Business Quant data shows IDXX's Revenue at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.